Publications

May 20, 2021

Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: data from the WAPPS database

Authors
Versloot O, Iserman E, Chelle P, Germini F, Edginton AN, Schutgens REG, Iorio A, Fischer K; Pharmacokinetic (PK) Expert Working Group of the International Prophylaxis Study Group (IPSG).
Citation
J Thromb Haemost. 2021 May 20. doi: 10.1111/jth.15395. Epub ahead of print. PMID: 34013558.
View Publication
May 11, 2021

Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: data from the WAPPS database

Authors
Versloot O, Iserman E, Chelle P, Germini F, Edginton AN, Schutgens REG, Iorio A, Fischer K; Pharmacokinetic (PK) Expert Working Group of the International Prophylaxis Study Group (IPSG).
Citation
Versloot O, Iserman E, Chelle P, Germini F, Edginton AN, Schutgens REG, Iorio A, Fischer K; Pharmacokinetic (PK) Expert Working Group of the International Prophylaxis Study Group (IPSG). Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database. J Thromb Haemost. 2021 Aug;19(8):1896-1906. doi: 10.1111/jth.15395. Epub 2021 Jun 18. PMID: 34013558; PMCID: PMC8361743.
View Publication
December 5, 2020

Not All Patients Benefit from Switching to Ehl: Results from the Wapps Database

The 62nd ASH Annual Meeting and Exposition (Dec 5-8, 2020)
Authors
Versloot O, Iserman E, Chelle P, Germini,F, Mathew T, Iorio A, and Fischer K
Citation
December 5, 2020

Terminal Half-Life of Factor VIII/IX According to Age and Blood Group Based on 8550 Assessments.

The 62nd ASH Annual Meeting and Exposition (Dec 5-8, 2020)
Authors
Versloot O, Iserman E, Chelle P, Germini,F, Mathew T, Iorio A, and Fischer K.
Citation
November 5, 2020

Not All Patients Benefit from Switching to Ehl: Results from the Wapps Database

Authors
Versloot O, Iserman E, Chelle P, Germini,F, Mathew T, Iorio A, and Fischer K
Citation
Blood 2020; 136 (S1): 21-22.
View Publication
November 5, 2020

Terminal Half-Life of Factor VIII/IX According to Age and Blood Group Based on 8550 Assessments

Authors
Versloot O, Iserman E, Chelle P, Germini,F, Mathew T, Iorio A, and Fischer K
Citation
Blood 2020; 136 (S1): 22-23
View Publication
January 22, 2019

Laboratory Assay Measurement of Modified Clotting Factor Concentrates: A Review of the Literature and Recommendations for Practice

Authors
Young G and Perry D on behalf of the International Prophylaxis Study Group (the IPSG)
Citation
Journal of Thrombosis and Haemostasis 2019: 17 (4): 567 – 573
View Publication
March 30, 2017

Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates

Authors
Iorio A, K. Fischer BM, Blanchette V, Rangarajan S, Young G, Morfini M, for the Pharmacokinetic (PK) Expert Working Group of the International Prophylaxis Study Group (the IPSG)
Citation
Thrombosis and Haemostasis 2017; 117 (6): 1023 - 1030
View Publication
August 22, 2010

Implications of coagulation factor VIII and IX pharmacokinetics for clinical practice.

Authors
Collins PW, et.al on behalf of the Pharmacokinetics in Prophylaxis Expert Working Group of the International Prophylaxis Study Group
Citation
Haemophilia 2011 Jan; 17(1):2-10.
View Publication